肠道菌群介导凤尾草总黄酮治疗前列腺炎的作用机制研究
首发时间:2024-01-19
摘要:目的:探讨凤尾草总黄酮(PME)治疗慢性前列腺炎(CP)的相关作用机制及其药效物质基础。方法:SD大鼠通过注射完全弗氏佐剂的方法制备CP大鼠模型,并随机分为5组:(1)正常对照组;(2)模型组;(3)阳性药普适泰组;(4)PME1组;(5)PME2组;阳性药、PME1、PME2组每天灌胃给药100 mg/kg,对照组和模型组灌胃生理盐水;给药5天停药2天,共给药6周,给药结束后采集大鼠粪便、血液、结肠内容物和前列腺组织。采用16S rDNA测序分析各组大鼠结肠肠道菌群;采用HPLC和UHPLC-TOF/MS方法分析PME的成分组成及肠道代谢变化。结果:PME能够改善CP大鼠炎症肿胀,降低TNF-α、IL-8和IL-10表达;PME通过下调嗜胆菌属、Dialister等有害菌属,上调乳杆菌、Ligilactobacillus等有益菌,从而改变肠道菌群结构,纠正CP模型大鼠的肠道菌群失调;PME主要成分为芹菜素、木犀草素及相关黄酮苷;体内外代谢结果表明,这些黄酮氧苷被肠道菌群代谢为对应苷元。结论:PME能够明显改善CP大鼠症状,其中的黄酮苷类成分可被肠道菌群代谢并发挥调节肠道菌群作用,PME和肠道菌群的相互作用可纠正肠道菌群失衡、抑制炎症因子表达而有助于CP治疗。
For information in English, please click here
Anti-prostatitis effect of the total flavonoids of Pteris multifida based on intestinal flora interaction
Abstract:Objective: To investigate the metabolisms and materialbasis for anti-chronic prostatitis (CP) effect of flavonoids from Pteris multifida.(PME).Methods: SD rats were injected with complete Freund\'s adjuvant to establish the CP rat model, and were randomly divided into 5 groups: (1) normal control group; (2) model group; (3) positive drug prostat group; (4) PME1 group; (5) PME2 group. The prostat, PME1, and PME2 groups were given 100 mg/kg by gavage daily, while the control group and model group were given normal saline by gavage. The drug was given for 5 days and stopped for 2 days, for a total of 6 weeks.After the end of the administration, feces, blood, colon contents, and prostate tissues were collected from the rats. The colonic intestinal flora of rats in each group was analyzed by 16S rDNA sequencing. The composition and intestinal metabolism changes of PME were analyzed by HPLC and UHPLC-TOF/MS methods. Results: PME exihibited potential in alleviating inflammation and swelling in CP rats, and reduce the level of TNF-α, IL-8, and IL-10. PME could modulatinf the structure of intestinal microbiotaandretify the imbalance of intestinal microbiotabydown-regulating harmful bacteria such as Bilophilia and Dialister, and up-regulating beneficial bacteria like Lactobacillus and Ligilactobacillus. The main components of PME were apigenin, luteolin, and related flavonoid glycosides. In vivo and in vitro results showed that these flavonoid glycosides were metabolized into corresponding glycosides by intestinal flora.Conclusion: The interaction between PME and the gut microbiota may contribute to the therapeutic effects of CP by modulating the composition and metabolites of intestinal. Results: PME demonstrated potential in Relieving inflammation and swelling of CP rats, as well as reducing the expression of TNF-α, IL-8, and IL-10. Additionally, it exhibited the ability to modulate the structure and balance of intestinal flora by down-regulating harmful bacteria such as choleophilus and Dialister while up-regulating beneficial bacteria like Lactobacillus and Ligilactobacillus. The primary constituents of PME consist of apigenin, luteolin, and their glycosides. In vivo and in vitro metabolism studies revealed that intestinal flora metabolized the O-glycosides of apigenin and luteolin into their respective aglycones; however, C-glycosides remained unmetabolized and were directly absorbed into the bloodstream. Conclusion: PME can significantly improve the symptoms of CP rats, and its flavonoid glycosides can be metabolized by intestinal flora and play a role in regulating intestinal flora. The interaction between PME and intestinal flora can correct the imbalance of intestinal flora, inhibit the expression of inflammatory factors, and contribute to the treatment of CP.
Keywords: Pteris multifida. chronic prostatitis flavonoids intestinal flora
引用
No.****
动态公开评议
共计0人参与
勘误表
肠道菌群介导凤尾草总黄酮治疗前列腺炎的作用机制研究
评论
全部评论0/1000